Ribeiro Ramiro 4
4 · EyePoint, Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
EyePoint (EYPT) CMO Ribeiro Ramiro Exercises Options, Sells Shares
What Happened
Ribeiro Ramiro, Chief Medical Officer of EyePoint, exercised a total of 4,875 option shares on 2026-06-30 (2,437 + 2,438 shares) at an exercise price of $8.26 per share (total cost ~$40,268). The filing shows he sold those shares the same day in the open market: 2,437 shares at $15.00 ($36,555) and 2,438 shares at a weighted average reported price of $15.02 ($36,612), for combined gross proceeds of $73,167. The filing also lists derivative entries showing $0 dispositions that reflect conversion/termination of the options upon exercise.
Key Details
- Transaction date: 2026-06-30 (filed 2026-07-02 — timely filing).
- Option exercise: 4,875 shares at $8.26 each (code M). Cost ≈ $40,268.
- Open-market sales: 2,437 shares at $15.00 and 2,438 shares at a weighted avg ~$15.02 (code S). Gross proceeds ≈ $73,167. Reported sale prices ranged $15.00–$15.06 (footnote F1).
- Footnote F2: Options vesting schedule — 25% vested Jan 3, 2026, remainder vesting monthly over the next three years.
- Shares owned after the transactions: not reported in the provided data.
- Codes explained: M = option exercise/conversion, S = sale.
Context
Exercising options and selling the resulting shares the same day is common when insiders cover the exercise cost and tax obligations; here the exercised shares were sold in the open market on the transaction date. This is a routine insider sale rather than a straightforward buy signal; factual details above show the exercise price, sale prices, and proceeds.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-06-30$8.26/sh+2,437$20,130→ 2,437 total - Exercise/Conversion
Common Stock
2026-06-30$8.26/sh+2,438$20,138→ 4,875 total - Sale
Common Stock
2026-06-30$15.00/sh−2,437$36,555→ 2,438 total - Sale
Common Stock
[F1]2026-06-30$15.02/sh−2,438$36,612→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2026-06-30−2,437→ 78,001 totalExercise: $8.26Exp: 2035-01-03→ Common Stock (2,437 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2026-06-30−2,438→ 75,563 totalExercise: $8.26Exp: 2035-01-03→ Common Stock (2,438 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.06. The reporting person undertakes to provide EyePoint Inc., any security holder of EyePoint Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.